Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis.
about
Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseasesHistone deacetylase signaling in cardioprotectionNovel epigenetic-based therapies useful in cardiovascular medicineHDAC and HDAC Inhibitor: From Cancer to Cardiovascular DiseasesStrategies to Enhance the Effectiveness of Adult Stem Cell Therapy for Ischemic Heart Diseases Affecting the Elderly PatientsEpigenetic associations in relation to cardiovascular prevention and therapeuticsHistone Deacetylases Exert Class-Specific Roles in Conditioning the Brain and Heart Against Acute Ischemic InjuryEmerging roles for histone deacetylases in pulmonary hypertension and right ventricular remodeling (2013 Grover Conference series)Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion.HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activationSpecific inhibition of HDAC4 in cardiac progenitor cells enhances myocardial repairs.Hepatic FoxO1 acetylation is involved in oleanolic acid-induced memory of glycemic control: novel findings from Study 2.Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium.HDAC inhibition elicits myocardial protective effect through modulation of MKK3/Akt-1.HDAC4 degradation mediates HDAC inhibition-induced protective effects against hypoxia/reoxygenation injury.Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms.Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure.Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice.Irisin Ameliorates Hypoxia/Reoxygenation-Induced Injury through Modulation of Histone Deacetylase 4Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts.Disruption of Nox2 and TNFRp55/p75 eliminates cardioprotection induced by anisomycin.A class of their own: exploring the nondeacetylase roles of class IIa HDACs in cardiovascular diseaseSuppression of Excessive Histone Deacetylases Activity in Diabetic Hearts Attenuates Myocardial Ischemia/Reperfusion Injury via Mitochondria Apoptosis Pathway.c-kit(+) cells: the tell-tale heart of cardiac regeneration?The relevance of epigenetics to occlusive cerebral and peripheral arterial disease.Translational Perspective on Epigenetics in Cardiovascular Disease.Cardiomyocyte marker expression in mouse embryonic fibroblasts by cell-free cardiomyocyte extract and epigenetic manipulation.New Aspects of Vascular Calcification: Histone Deacetylases and Beyond.Class I HDAC inhibition stimulates cardiac protein SUMOylation through a post-translational mechanism.Sodium Butyrate Protects -Against High Fat Diet-Induced Cardiac Dysfunction and Metabolic Disorders in Type II Diabetic Mice.HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury.Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation.Interplay of Histone Marks with Serine ADP-Ribosylation
P2860
Q21284678-ACCD5694-609A-491D-86A8-2B239ADD40EAQ24568237-6070E595-6793-4BA7-B4D8-6170AC0A4D69Q26765152-15A04E77-1E10-4786-A08A-CF864EED3CEDQ26766640-FBCFBD10-96C7-410F-AFE3-E063B96C5E65Q26771298-82BD6527-5A3C-41F0-A16C-B4227FA8A88AQ26771428-D1402D8E-7114-4187-B3F9-DD076082C265Q26801660-2450E2BA-B162-4D6A-B8F0-1EB13EC033B2Q28082797-53374514-D44B-47B2-8ED0-61E7006DADBDQ33714350-3E0961FD-5C07-437D-8DDE-B3365175F36AQ33891516-B3BF0C7D-1E84-4B51-AA04-44DDAA775514Q34062891-1FE445CE-622C-444E-8895-9D55EA098FE7Q34183986-17C89487-D23C-4DD1-83C2-E95055E28682Q34355984-79B135E6-6471-4427-B7E3-B44F4FE65845Q34769978-E7B5232E-413B-42CB-BE73-23DE0640E025Q35216855-5F77EB1F-01C5-4586-9931-1AA053CCA87FQ35517710-E0F26646-982A-48A9-9022-EC6C2878E45FQ35723859-AF1215AA-A5D6-4192-AF90-69E8170AF9DFQ35922922-7F48F422-135E-456A-BE08-D0429AEC5CFCQ36201061-789640B6-030F-4588-8495-567FD44ACAF0Q36408024-B4C2B53F-4F17-4CDC-B7BE-5AB4D72F035AQ36454212-C2FCC221-96B0-4EA8-A387-A6CF8079488AQ37218059-845F64AB-05D2-423D-A032-E2EF134B6308Q37612026-03702712-7BC9-4329-ADD5-54D76B5F3AB6Q38313140-44B598D5-CDEA-4BC0-A7B7-D96007F3284BQ38351869-9530868D-3D09-4880-AAF8-7BB5C7B56559Q38650827-DBF32C6D-D3DB-4B0E-9965-26CC7488DF6DQ38846109-006D1981-5F9A-4978-A925-8F732FC1082FQ42702677-4BACBAC1-E18C-49F9-A52C-4926A60517BFQ43051844-0BEE370F-C116-44A4-8F44-DCA8D904D59AQ46429786-C301D7A1-956B-4468-95AB-546D74832128Q47682735-82335F81-0992-4FE4-812A-85CEB2AF36C8Q47978008-9993363A-0CE3-4745-96EA-62EF4E8308C8Q48162963-E1045DC8-D67B-47B0-96EC-3EAC8D26E325Q58697556-D35C2A60-30E9-4AF6-9AE7-2633D219C175
P2860
Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Inhibition of histone deacetyl ...... of endogenous angiomyogenesis.
@ast
Inhibition of histone deacetyl ...... of endogenous angiomyogenesis.
@en
type
label
Inhibition of histone deacetyl ...... of endogenous angiomyogenesis.
@ast
Inhibition of histone deacetyl ...... of endogenous angiomyogenesis.
@en
prefLabel
Inhibition of histone deacetyl ...... of endogenous angiomyogenesis.
@ast
Inhibition of histone deacetyl ...... of endogenous angiomyogenesis.
@en
P2093
P2860
P356
P1476
Inhibition of histone deacetyl ...... of endogenous angiomyogenesis.
@en
P2093
Guangmao Cheng
Ling Zhang
Loren Fast
Shougang Zhuang
Ting C Zhao
P2860
P304
P356
10.1124/JPET.111.189910
P407
P577
2012-01-23T00:00:00Z